Phosphoribosyl pyrophosphate synthetases 2 knockdown inhibits prostate cancer progression by suppressing cell cycle and inducing cell apoptosis

Abstract

Phosphoribosyl pyrophosphate synthetases 2 (PRPS2) protein function as nucleotide synthesis enzyme that plays vital roles in cancer biology. However, the expression profile and function of PRPS2 in prostate cancer (PCa) remain to be identified. Here we investigated the expression of PRPS2 protein in human PCa and paired normal tissues by immunohistochemistry, meanwhile the regulatory effects on cell proliferation, apoptosis and growth of xenograft tumors in nude mice were evaluated in PCa cells with PRPS2 depletion. Moreover, the signaling pathways were also explored by western blot analysis and quantitative polymerase chain reaction assays. We found that PRPS2 was dramatically upregulated in prostate adenocarcinoma tissues in comparison with normal tissues, and that increased PRPS2 was linked intimately to advanced clinical stage and pT status. Functional experiments showed that knockdown of PRPS2 significantly suppressed cell growth both in vitro and in vivo. In addition, depletion of PRPS2 induced G1 phase cell cycle arrest and elevated cell apoptosis. Silencing of PRPS2 resulted in the decreased expression of Bcl-2 and cyclinD1 and increased levels of Bax, cleavage of caspases-3, caspases-9 and PARP. Furthermore, we also detected PRPS2 expression was significantly induced after DHT treatment, which implied the important role of PRPS2 in oncogenesis of PCa. Taken together, our findings elucidated that PRPS2 may be a potential novel candidate for PCa therapy.

LncRNA SNHG1 and RNA binding protein hnRNPL form a complex and coregulate CDH1 to boost the growth and metastasis of prostate cancer

“…Prostate tissue IHC were employed to investigate protein expression in tissues as described previously. Relative proteins expression was investigated in Prostate tissue IHC as previously referred to 32 . In IHC, we incubated the specimens with 1: 500 anti-Ki-67 antibodies.…”

Transcription Factor AP4 Mediates Cell Fate Decisions: To Divide, Age, or Die

“…Ribose-phosphate pyrophosphokinase 2, PRPS2, is an enzyme involved in nucleotide biosynthesis which is essential for tumorigenesis driven by c-Myc [ 68 ]. It is also needed for cell invasion and proliferation in colorectal cancer [ 69 ] and prostate cancer [ 70 ]. It remains to be determined whether AP4 regulates the expression of SDC1 and PRPS2 and plays a role in disease progression via these two genes in these cancer types.…”

The Proteome Profile of Olfactory Ecto-Mesenchymal Stem Cells-Derived from Patients with Familial Alzheimer’s Disease Reveals New Insights for AD Study

“…A key player in the production of purines and pyrimidines, phosphoribosyl pyrophosphate synthetase 2 ( PRPS2 ) acts as an oncogene by controlling the activities of matrix metalloproteinase 9 and the expression of E-Cadherin [ 100 , 101 ]. The tumor suppressor gene TSC2 (Tuberous Sclerosis Complex subunit 2 or Tuberin) negatively controls mTORC1 signaling and is crucial for autophagy and dendritic formation [ 102 , 103 ].…”